Hope Never Dies

01/07/2026

There is no single anti-cancer nutrition plan that works for everyone. The real work is understanding the metabolic environment inside the body and how nutrition can influence it.

Dr. Jeanne Wallace, one of the leading voices in nutritional oncology, has spent decades helping patients use targeted nutrition to create a biological environment that is less supportive of tumor growth. Her approach integrates evidence based food strategies with conventional care to help people strengthen their overall treatment plan.

For a clear introduction to how personalized cancer nutrition works and why the metabolic environment matters so much, read:

Dietary & lifestyle strategies to modulate the environment within the body for a less favorable host for tumor growth | Anti-Cancer Nutrition

12/29/2025

Sarcomas are rare overall but disproportionately affect children and young adults, making up about 15% of childhood cancers versus

12/26/2025

Dr. Elizabeth Panke was diagnosed with ovarian cancer in 1999 and was given two months to live. She shares her from her journey to wellness.

12/23/2025

Most chemotherapy decisions follow standardized national guidelines. These guidelines are based on many studies, but they do not account for the unique microenvironment and molecular activity inside each patient’s body.

Pioneer Dr. Robert Nagourney developed a personalized approach known as functional profiling. This process includes testing a patient's own cancer cells against multiple treatments in the lab to see how their cancer cells respond when exposed to a variety of drugs and drug combinations -- before administering them to the patient.

For anyone exploring chemotherapy as part of their cancer plan, this is essential reading. https://hopeneverdies.com/2021/02/which-chemotherapy-drugs-are-best/

Nagourney Cancer Institute

Dr. Nagourney’s functional profiling testing offers a personalized roadmap for the chemo drugs best for treating your specific cancer.

12/19/2025

Modern advancements in oncology enable us not only to assess the efficacy of chemotherapy and "Standard of Care" treatments, but also to delve into how specific targeted agents (like genomic profiling) work.

12/10/2025

Ivermectin has gained a lot of attention online as a possible cancer therapy, but the research is still early. Most of the findings come from lab and animal studies using doses higher than what is safe for people. A single breast cancer clinical trial is in progress, and until human data is published, there is no strong evidence that ivermectin is an effective cancer treatment.

Some integrative oncologists note that ivermectin has a good safety profile at typical doses, but also point out that many proven therapies receive far less attention. Replacing conventional treatment with experimental drugs can carry risks, especially when evidence is limited.

If you are curious about Ivermectin or any repurposed drug, your care plan should always come first. Understanding what is supported in human studies, and what is still experimental helps you make informed choices appropriate to your cancer and your needs. https://cancerchoices.org/ivermectin-and-cancer-a-closer-look-at-its-use-and-risks/ Donnie Yance

12/01/2025

There is plenty of hype in the longevity world, but not all of it is meaningful. In a recent interview, nutritionist and master herbalist Donnie Yance explains why lasting health has much more to do with how the body responds to stress, inflammation, and nourishment.

He discusses adaptogens, a category of botanicals first identified by Russian researchers in the 1960s, and how they can help the body handle stress more efficiently. He also highlights the role of mindset, movement, and mostly plant-based eating patterns seen in long-lived populations.

It is a thoughtful look at building strength from the inside out.

People have been searching for the fountain of youth for centuries, fueling a longevity industry that often influences us with novelty solutions. Certified n...

11/25/2025

An oncogene is a mutated gene that has the potential to cause cancer. DNA changes in cancer cells turn these genes on permanently, leading to uncontrolled cell growth.

11/21/2025

Immunotherapy clinical trials are opening doors for more patients, including some first-line settings. Yet only 3 to 6 percent of eligible patients enroll.

If you are exploring options, learn how immunotherapy trials work, what to ask, and how a navigator can match you to open studies.

Understanding the process can expand your choices and your hope. https://www.cancerresearch.org/cancer-clinical-trials

Cancer clinical trials are critical to bringing new treatments to more patients. See if immunotherapy clinical trials are right for you.

11/17/2025

Chronic inflammation plays a major role in cancer growth and progression, which is why many integrative oncologists and researchers focus on anti-inflammatory strategies alongside standard treatment. One natural compound frequently studied in this area is curcumin, the active ingredient in turmeric.

Research from preclinical, animal, and human studies has shown that curcumin can help suppress inflammatory pathways that contribute to cancer cell growth and tumor spread. Many patients use it as part of a broader protocol to support the body and help reduce inflammation, often in combination with conventional treatment.

This blog breaks down what the science says, how curcumin works, dosage considerations, and important notes about absorption and drug interactions. If you are looking for evidence-based supplements to discuss with your care team, this is a valuable starting point. https://hopeneverdies.com/2021/02/curcumin-a-powerful-anti-cancer-agent/